Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03973879
Title Combination of PVSRIPO and Atezolizumab for Adults With Recurrent Malignant Glioma
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Darell D. Bigner, MD, PhD

high grade glioma


Atezolizumab + PVSRIPO

Age Groups: adult | senior
Covered Countries

No variant requirements are available.